Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
Titel:
Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
Auteur:
Chavez, Julio C Grajales, Ariel Sandoval-Sus, Jose Turba, Elyce Nodzon, Lisa Uriepero-Palma, Angimar Ammad-Ud-Din, Mohammad Sahakian, Eva Komrokji, Rami Sokol, Lubomir Locke, Frederick L Shah, Bijal Lancet, Jeffrey Sotomayor, Eduardo M Kharfan-Dabaja, Mohamed A. Bello, Celeste Pinilla-Ibarz, Javier